Risk of infection in multiple users of fingersticks
The Centers for Disease Control and Prevention and FDA have noted an increase in reports of bloodborne infection transmission, primarily hepatitis B virus, resulting from shared use of fingerstick and point-of-care blood testing devices.
The Centers for Disease Control and Prevention and FDA have noted an increase in reports of bloodborne infection transmission, primarily hepatitis B virus, resulting from the shared use of fingerstick and point-of-care (POC) blood testing devices. Unclear labeling and ineffective cleaning and disinfection instructions may have contributed to these outbreaks.
The infections are occurring in a variety of healthcare settings, but there is a significant increase in outbreaks in long-term care or assisted-living settings.
Fingerstick and POC blood testing devices can be safely used multiple times by a single patient in the home setting, provided that the user follows the label cleaning instructions.
CDC recommends nirsevimab be prioritized for highest-risk infants amid limited availability
October 26th 2023The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies
October 21st 2023Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.
